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Abstract
Background: Optimal androgen signaling is critical for testicular development and spermatogenesis.
Methoxyacetic acid (MAA), the primary active metabolite of the industrial chemical ethylene glycol monomethyl
ether, disrupts spermatogenesis and causes testicular atrophy. Transcriptional trans-activation studies have indicated
that MAA can enhance androgen receptor activity, however, whether MAA actually impacts the expression of
androgen-responsive genes in vivo, and which genes might be affected is not known.
Methods: A mouse TM3 Leydig cell line that stably expresses androgen receptor (TM3-AR) was prepared and
analyzed by transcriptional profiling to identify target gene interactions between MAA and testosterone on a
global scale.
Results: MAA is shown to have widespread effects on androgen-responsive genes, affecting processes ranging
from apoptosis to ion transport, cell adhesion, phosphorylation and transcription, with MAA able to enhance, as
well as antagonize, androgenic responses. Moreover, testosterone is shown to exert both positive and negative
effects on MAA gene responses. Motif analysis indicated that binding sites for FOX, HOX, LEF/TCF, STAT5 and MEF2
family transcription factors are among the most highly enriched in genes regulated by testosterone and MAA.
Notably, 65 FOXO targets were repressed by testosterone or showed repression enhanced by MAA with
testosterone; these include 16 genes associated with developmental processes, six of which are Hox genes.
Conclusions: These findings highlight the complex interactions between testosterone and MAA, and provide
insight into the effects of MAA exposure on androgen-dependent processes in a Leydig cell model.
Background
Androgen signaling is critical for development of the
male sexual phenotype, maturation of secondary sex
characteristics and maintenance of muscle mass and
bone density [1]. Disruption of androgen signaling can
lead to a spectrum of developmental problems in male
sexual characteristics and reproductive behavior [2].
Androgen action is mediated by androgen binding to
androgen receptor (AR), a ligand-activated transcription
factor that binds genomic regulatory elements associated
with androgen responsive genes [3]. AR binding sites are
often far (>10 kb) from transcription start sites of
androgen-regulated genes, and many AR binding sites
contain non-canonical androgen response elements
[4-6]. Many transcription factors interact with AR,
including GATA factors [7], STAT5 [8], NF1 and SP1
[9], which can increase AR transcriptional activity, as
well as Forkhead proteins [10-12], P53 [13] and LEF/
TCF factors [14], which are reported to exert both
repression and enhancement of AR transcriptional activ-
ity. Some of these effects may involve local interactions,
as binding sites for GATA and Forkhead, as well as
OCT family factors are often enriched nearby AR bind-
ing sites [4-6]. These findings suggest that physiological
or pathophysiological conditions that affect the expres-
sion or activity of AR-interacting transcription factors
such as these may impact AR activity.
Many foreign chemicals can modulate AR activity;
these include drugs and environmental chemicals that
bind directly to AR and antagonize its transcriptional
activity [15,16]. AR activity can also be modulated by
foreign chemicals that exert effects on AR indirectly, via
intracellular signaling [17,18]. One example is methox-
yacetic acid (MAA), a testicular toxicant and the
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ethylene glycol monomethyl ether [19,20]. MAA
enhances the transcriptional activity of several nuclear
receptors [21,22], including AR [19,22-24], by a mechan-
ism that involves tyrosine kinase activity and requires
PI3-kinase signaling [22]. T h ei n a p p r o p r i a t ee n h a n c e -
ment of AR transcriptional activity by MAA could con-
tribute to the testicular toxicity associated with MAA
exposure, given the importance of AR in somatic cells
of the testis for spermatocyte survival [25].
Earlier studies of the potentiation of AR transcrip-
tional activity by MAA used AR reporter gene assays to
demonstrate enhancement of androgen response [22].
However, while reporter gene assays are an important
tool for studying gene regulation, transfected reporter
gene constructs do not always reflect the regulation of
endogenous genes in untransfected cells in vivo.M o r e -
over, in the case of MAA, artefactual effects on the
CMV promoter used in one study to express estrogen
receptor required for reporter gene activity were
reported [26]. It is therefore important to determine the
effects of MAA on the expression of endogenous andro-
gen responsive genes to determine whether MAA can,
indeed, potentiate androgen responses, to identify the
specific genes whose expression is affected, and to eluci-
date the nature and extent of interactions between
MAA and androgen, both positive and negative.
In this study, we develop an androgen-responsive mouse
testicular Leydig cell line, TM3-AR, and use it to investigate
the impact of MAA on androgen responsive gene expres-
sion by global transcriptional profiling. Our findings reveal
that MAA alters the expression of large numbers of testos-
terone-responsive genes. We also find that the androgenic
environment can influence the effects of MAA on gene
expression, with many examples of both stimulatory and
inhibitory interactions between MAA and testosterone.
Motif analysis identified binding sites for transcription fac-
tors whose putative targets are enriched in genes showing
either positive or negative interactions between MAA and
testosterone, providing further insight into the mechanisms
that govern these gene interactions. Enriched micro-RNA
binding sites in the 3’-untranslated region (3’-UTR) of tar-
get genes were also identified. These findings demonstrate
that the impact of MAA on androgen gene responses is
complex and suggest target genes and pathways through
which MAA may exert toxicity to somatic cells of the testis.
Methods
Chemicals and reagents
MAA, horse serum and testosterone were purchased
from Sigma Chemical Co, St. Louis, MO. DMEM-F12
culture medium, fetal bovine serum (FBS), HEPES buffer
and TRIzol reagent were purchased from Invitrogen
Corp. (Carlsbad, CA).
Cell culture and TM3-AR cell preparation
Mouse TM3 Leydig cells and LNCaP cells were obtained
from American Type Culture Collection, Manassas, VA.
TM3 and TM3-AR cells (see below) were grown in
DMEM-F12 medium containing 5% horse serum and
2.5% FBS. LNCaP cells were maintained in RPMI 1640
containing 10% FBS. RNA was isolated using TRIzol
reagent using the manufacturer’sp r o t o c o l .M o u s eT M 3
cells stably expressing human AR cDNA were prepared
by retroviral infection of TM3 cells, as follows. The cod-
ing sequence of AR was excised from plasmid pSV-ARO
(Dr. A.O. Brinkmann, University Medical Center Rotter-
dam, The Netherlands) and subcloned by blunt end liga-
tion into the retroviral plasmid vector pWZL-Blast (Dr.
D. White, Millenium Pharmaceuticals, Cambridge MA)
to yield pWZL-Blast-AR. pWZL-Blast is based on the
pBabe plasmid [27] and encodes a blasticidin-resistance
gene transcribed from the retroviral long terminal
repeat. Retroviral particles were generated as described
[28] by transfecting the packaging cell line HEK293 with
pWZL-Blast-AR. Culture medium containing retroviral
particles was collected 48 h later and applied to TM3
cells. Pools of blasticidin-resistant cells were selected for
4 days using blasticidin S-hydrochloride and then veri-
fied as expressing AR by qPCR.
To obtain samples for microarray analysis, TM3-AR cells
were treated for 24 hr with either testosterone (10 nM) or
MAA (5 mM), or with testosterone in combination with
MAA. The concentration of testosterone was chosen to
saturate AR, and the concentration of MAA was chosen
based on considerations described in our earlier studies
[22,29], and based on its correspondence to the plasma
concentration associated with ethylene glycol monomethyl
ether-induced germ cell toxicity in mice [30]. The concen-
tration of MAA used did not alter the cell growth rate or
cause any loss of cell viability over the course of at least 48
hr. RNA was isolated and validated by RNA integrity num-
ber >8.5, as determined using an Agilent Bioanalyzer 2100
instrument (Agilent Technologies, Santa Clara, CA).
qPCR
Total RNA isolated from treated or untreated cultured
cells was incubated with RQ1 RNAse-free DNAse for 1
h at 37°C followed by heating at 75°C for 5 min. cDNA
synthesis and qPCR analysis using SYBR Green I-based
chemistry were performed as described [31]. Dissocia-
tion curves were examined after each qPCR run to
ensure amplification of a single, specific product. qPCR
primers were designed using Primer Express software
(Applied Biosystems) and are shown in Additional file 1,
Table S1. Relative RNA levels were calculated after nor-
malization to the 18S rRNA content of each sample
using the comparative Ct method, under conditions
where the Ct number is in its log2 linear range.
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Each RNA sample used for microarray analysis was a
pool prepared from three independent TM3-AR cell cul-
tures (three different passages), each treated as described
above. Two such pools of TM3-AR cell RNA (represent-
ing a total of 5 independent treated cell cultures) were
prepared and used in two independent sets of microar-
rays, each of which represented 3 of the 5 independent
cultures. Each set of microarrays was comprised of four
separate competitive hybridization arrays (i.e., four
microarray experiments): testosterone vs. control, MAA
vs. control, testosterone + MAA vs. testosterone, and
testosterone + MAA vs. MAA. This approach, employ-
ing pools of biological replicates, minimizes the impact
of culture-to-culture variations that are unrelated to the
treatments per se. cDNAs transcribed from each pooled
RNA sample were labeled with Alexa 647 or Alexa 555
dyes in a fluorescent reverse pair design (dye swap) for
competitive hybridization to Agilent Whole Genome
Mouse Microarrays (Agilent Technology, array platform
G4122F). Sample labeling, hybridization to microarrays,
scanning, analysis of TIFF images using Agilent’s feature
extraction software, calculation of linear and LOWESS
normalized expression ratios and p-value calculation
using Rosetta Resolver (version 5.1, Rosetta Biosoftware)
were carried out as described [32,33]. For dye swapping
experiments, the Alexa 555-labeled RNA from one of
the treatment conditions (testosterone and/or MAA
treated) was mixed with Alexa 647-labeled RNA for the
appropriate reference control (as specified above), and
vice versa. Features flagged as saturated in both fluores-
cence channels or flagged as non-uniformity outliers in
either channel were excluded from analysis. The full set
of normalized expression ratios and p-values is available
at the Gene Expression Omnibus web site of NCBI [34]
as GEO series GSE27410.
Microarray annotation and statistical analysis
Agilent mouse microarray G4122F contains 41,174
mouse probes (features), each 60-nt in length. Accession
numbers were obtained for 39,355 out of the 41,174
probes, of which 33,011 were assigned gene names. An
additional 3,570 probes were assigned gene names using
the microarray probe annotation tool AILUN [35], which
maps microarray probes to Entrez genes. Each probe cor-
responding to a distinct mouse transcript is referred to as
representing a separate gene/gene product. For each
microarray probe, a mean fold-change and p-value was
calculated based on the set of microarray expression
ratios using the Rosetta Resolver-based error model [32].
The error model uses technology-specific data para-
meters to stabilize intensity variation estimates, along
with error-weighted averaging of replicates. This
approach has been demonstrated to provide an effective
increase in statistical power [32]. The statistical signifi-
cance of differential expression of each gene was deter-
mined by application of a filter (p < 0.005) to the
Rosetta-generated p-values. Next, a |fold-change| filter of
>2-fold was combined with the above p-value filter to
determine the number of probes that were differentially
regulated in any of the four microarray experiments. In
total, 6,416 probes met the combined thresholds for dif-
ferential expression (|fold-change| >2) and statistical sig-
nificance (p < 0.005) in at least one of the four
experiments. In those cases where two or more differen-
tially expressed probes mapped to the same gene and
gave the same pattern of expression across all four
microarrays (reflecting probe redundancy in the array
platform), a single representative probe was retained in
the final data set. A total of 884 redundant probes were
thus eliminated, giving a total of 5,532 non-redundant
probes that met the threshold criteria for both differential
expression (|fold-change| >2) and statistical significance
(p < 0.005) in at least one of the four experiments (Addi-
tional file 2, Table S2A). The number of probes expected
to meet the combined threshold by chance is 0.005 ×
6,416, or 32 probes. The actual number of probes meet-
ing the combined threshold was 7,811, corresponding to
an apparent false discovery rate of 32/7,811, or 0.41%.
Commonly used multiple testing correction methods
such as Bonferroni or Holm step-down were not applied
as these eliminate a large number of true positives and
introduce an inappropriate overcorrection.
A system of binary and decimal flags, termed total flag
sum (TFS), was used to cluster the differentially regulated
genes into subgroups based on their patterns of expres-
sion across the four microarray experiments [36]. Briefly,
all genes that met the above fold-change and p-value
threshold criteria for one or more of the four microarray
e x p e r i m e n t sw e r ea s s i g n e dab i n a r yf l a gv a l u eo f1 ,2 ,4
and 8 respectively. The sum of these binary flag values
defines the whole number portion of the flag assigned to
each gene and indicates which of the four microarrays
met the specified threshold criteria in our analysis. In
addition, decimal values of 0.1, 0.01, 0.001 and 0.0001, or
0.2, 0.02, 0.002, and 0.0002 were respectively assigned to
each of the four microarrays to indicate the direction of
regulation of the genes in the array (decimal flags with
values of 1 indicate up-regulation, whereas those with a
value of 2 indicate down-regulation). Thus, for each
gene, the TFS group designation, comprising the binary
sum plus the decimal values, indicates which of the four
arrays met the threshold criteria for inclusion and the
direction of regulation, as outlined in Additional file 2,
Table S2B. As an example, the 472 genes in TFS group
9.1001 (see Table 1, below) all meet the combined
threshold for up regulated expression in array experi-
ments 1 and 4 (testosterone vs. control, and testosterone
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ments 2 and 3 (MAA vs. control, and testosterone +
MAA vs. testosterone). The whole number portion of the
TFS group number, 9, equals the sum of the binary flag
values 1 + 8, i.e., significant regulation on the 1
st and 4
th
array experiments. Similarly, TFS group 6.0220 indicates
down regulation in the 2
nd and 3
rd array experiments, etc.
Gene Ontology (GO) and motif enrichment analysis
GO term enrichment analysis for each TFS group was
carried out using DAVID data sets [37]. Briefly, genes in
each TFS group were iteratively compared with genes in
each gene set that share a common GO term, and the
number of overlapping genes was used to calculate an
enrichment score and a Fisher’se x a c tt e s tp-value for
each TFS group and each gene set. GO terms enriched
at p < 0.001 and containing >5 genes with the specific
GO term for at least one TFS group were selected, and
TFS groups with at least one enriched GO term were
selected. A total of 156 unique GO terms enriched in 17
TFS groups were obtained (Additional file 3, Table
S3A). Hierarchical clustering was implemented using
Cluster [38], and a corresponding heat map was drawn
using Java Treeview [39]. Cis-regulatory elements asso-
ciated with the gene expression changes induced by tes-
t o s t e r o n ea n dM A Aw e r ei d e n t i f i e db yg e n es e t
enrichment analysis (GSEA) by searching each group of
genes against the 836 motif gene sets and against the
221 predicted microRNA (miRNA) target gene sets that
comprise the C3 module of the Molecular Signatures
database [40]. The motif gene sets contain genes sharing
a cis-regulatory motif conserved across the human,










I No interaction between T and MAA 9.1001 472 Up - - Up
9.2002 492 Down - - Down
6.0110 350 - Up Up -
6.0220 174 - Down Down -
3.1100 53 Up Up - -
3.2200 55 Down Down - -
15.2112 59 Down Up Up Down
IIa MAA enhances action of T 8.0001 421 - - - Up
8.0002 398 - - - Down
14.0111 60 - Up Up Up
14.0222 24 - Down Down Down
IIb T enhances action of MAA 4.0010 355 - - Up -
4.0020 264 - - Down -
13.1011 144 Up - Up Up
13.2022 56 Down - Down Down
IIc T enhances action of MAA, and MAA enhances action of T 15.1111 77 Up Up Up Up
15.2222 39 Down Down Down Down
12.0011 316 - - Up Up
12.0022 81 - - Down Down
IIIa MAA blocks action of T 1.1000 329 Up - - -
1.2000 307 Down - - -
IIIb T blocks action of MAA 2.0100 302 - Up - -
2.0200 165 - Down - -
IIIc MAA blocks the action of T, but MAA alone shows no
activity
5.1020 62 Up - Down -
5.2010 52 Down - Up -
IIId T blocks the action of MAA, but T alone shows no activity 10.0102 107 - Up - Down
10.0201 16 - Down - Up
Regulated genes were clustered based on whether there is an interaction between testosterone and MAA, as follows: Class I represents genes that respond to
testosterone or to MAA with no interactive effect. Class II represents genes whose response to testosterone was enhanced by MAA (IIa), genes whose response
to MAA was enhanced by testosterone (IIb), and genes whose responses to testosterone and MAA showed mutual enhancement (IIc). Class III corresponds to
genes whose response to testosterone could be blocked by MAA (IIIa, IIIc) or whose response to MAA could be blocked by testosterone (IIIb, IIId). See Additional
file 2, Table S2C for further details.
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known or likely transcription factor binding sites in a 4
kb genomic region centered on the transcription start
site of each gene. The miRNA target gene sets are com-
prised of genes with the corresponding miRNA binding
sites present in 3’-UTR sequences.
Results
Generation of TM3-AR cells and AR expression
TM3 mouse Leydig cells are reported to be MAA
responsive [19], however, we found AR expression to be
very low, and correspondingly, the androgen responsive-
ness of these cells was very weak, as judged by qPCR
analysis (Figure 1). To increase the androgen response,
AR cDNA was stably transfected into TM3 cells using a
retroviral vector. The resulting pool of TM3-AR cells
showed a marked increase in AR expression, comparable
to that of the widely studied androgen responsive cell
line LNCaP (Figure 1A). The androgen responsiveness
of TM3-AR cells was confirmed by the ~5-fold increase
in expression of Rhox5 (Pem) and by the ~10 fold
decrease in expression of Igfbp3 following testosterone
treatment; neither gene showed a significant response to
testosterone in TM3 cells,b u tt h er e p r e s s i o no fIgfbp3
by MAA [22] was evident in both cell lines (Figure 1B).
Impact of MAA on TM3-AR cell gene expression
The global impact of MAA on androgen-responsive
gene expression was evaluated by microarray analysis.
TM3-AR cells were treated for 24 h either with testos-
terone, MAA, a combination of testosterone and MAA,
or vehicle control. Total RNA from each group was
then analyzed on whole-mouse genome two-color
expression microarrays for the following four compari-
sons: Array 1, testosterone vs. control; Array 2, MAA vs.
control; Array 3, testosterone + MAA vs. testosterone;
Array 4, testosterone + MAA vs. MAA. Normalized
expression ratios and p-values were determined, and
genes meeting our combined threshold for significance
(|fold-change| > 2 and p < 0.005; see Methods) for at
least one of the four microarray comparisons were iden-
tified. A total of 5,532 genes of interest were thus
obtained after elimination of redundant probes. Hier-
archical clustering of these 5,532 genes revealed closest
correlation between arrays 1 and 4 (effects of testoster-
one in the absence and presence of MAA, respectively),
and, to a lesser extent, between arrays 2 and 3 (effects
of MAA in the absence and presence of testosterone,
respectively) (Figure 2). A complete listing of these
genes, along with their expression ratios, measured sig-
nal intensities and gene annotations is provided in Addi-
tional file 2, Table S2A. Testosterone induced 1,233
genes and repressed 1,205 genes (array 1), while MAA
induced 1,206 genes and repressed 525 genes (array 2).
Figure 1 qPCR analysis of the expression of AR (A),
testosterone induced gene Pem (B) and testosterone repressed
gene Igfbp3 (B). In A, infection of TM3 cells with retorvirus
expressing AR cDNA is shown to lead to AR expression at a level
similar to that of LNCaP prostate cancer cells. Significantly different
from TM3 cells at p < 0.001 (***). In B, cells were untreated (DMSO
vehicle alone, -), or were treated for 24 hr with testosterone (T, 10
nM), MAA (M, 5 mM), or with T + MAA, as indicated. Rhox5 is a
testosterone-inducible Sertoli cell marker gene that is also expressed
at a low level in Leydig cells in vivo [56]. Igfbp3 is repressed by
testosterone, and by MAA [22], with the latter response also seen in
the TM3 cells deficient in AR. Data are mean ± SD values based on
n = 3 replicates, with the untreated TM3 cell value set to 1.0.
Significantly different from untreated control at p < 0.05 (*) or at p
< 0.001 (***); significantly different from T at p < 0.05 (#) or at p <
0.001 (###); and significantly different from MAA at p < 0.001 (+++).
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genes and repressed 748 genes when compared with tes-
tosterone treatment alone (array 3), while 1,587 genes
were induced and 1,396 genes were repressed by testos-
terone + MAA, when compared with MAA treatment
alone (array 4). Among the genes induced by testoster-
one were Rhox5 (Pem) [41] and Amotl1 [42], two well-
characterized androgen-inducible genes. 87% of the
MAA-responsive genes in TM3-AR cells identified on
array 2 overlap with the set of MAA-responsive genes
that we previously identified in TM3 cells that do not
express AR [29], validating the robustness of the MAA
response. Ingenuity Pathway Analysis revealed testoster-
one related gene networks that respond to MAA; these
include cell death and cellular development, reproduc-
tive system disease, and small molecule biochemistry
(Figure 3 and Additional file 4, Figure S1).
MAA affects androgen response in multiple ways:
clustering by significance and differential expression
The impact of MAA on testosterone gene responses was
investigated by classification of the regulated genes using
a binary flagging system [36], whereby each gene was
assigned to a specific category, termed TFS (total flagging
sum), based upon its expression ratio and p-value in each
of the four microarray experiments (Additional file 2,
Table S2B). This system provides a simple way to identify
gene groups that responded to testosterone or MAA and
to determine whether there is any interaction between
them. Of the 5,532 genes of interest, 5,230 (95%) could
be grouped into four major classes based on the interac-
tions of testosterone and MAA (Table 1 and Additional
file 2, Table S2C). Class I is comprised of 1,655 genes
(30% of the total) distributed into 7 TFS gene groups.
These genes responded to testosterone and/or MAA but
showed no interaction between testosterone and MAA.
Class II is comprised of 2,235 genes (40%) distributed
into 12 TFS groups. These genes displayed positive inter-
actions between testosterone and MAA, i.e., testosterone
Figure 2 Heat map displaying the effects of testosterone, MAA
or both in combination on TM3-AR cell gene expression.
Shown is the hierarchical clustering heat map of 5,532 responsive
genes based on log2 ratios, with the scale as shown at the bottom,
right. T, testosterone; UT, untreated.
Figure 3 Top network affected by MAA.T h i sn e t w o r kw a s
identified by Ingenuity Pathway Analysis, and involves cell death,
cellular development and cell-to-cell signaling and interaction.
Dashed arrows indicate regulation of gene expression, arrows with
solid lines represent protein-DNA interactions, and solid lines
indicate protein-protein interactions. Lines in blue identify factors
and processes directly connected to testosterone.
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combination of both agents induced gene responses not
observed with the individual treatments. Class III is com-
prised of 1,240 genes (24%) distributed into 8 TFS
groups. These genes showed negative interactions
between testosterone and MAA, i.e., the response to tes-
tosterone could either be blocked or reversed by MAA,
or vice versa. The remaining 302 genes were distributed
into 25 small TFS groups and were not considered
further (Additional file 2, Table S2C).
It should be noted that the induction or repression
observed by treating with testosterone + MAA is being
compared with that obtained with testosterone alone
(array 3) or to MAA alone (array 4), and not to the vehi-
cle-treated control. In case of class III genes, this is of par-
ticular importance, as in some cases, testosterone alone
may cause gene induction, while treatment with testoster-
one + MAA might cause repression relative to the level of
expression with testosterone alone but not when com-
pared to vehicle control. For example, in case of Cep70 in
TFS group 5.2010, the microarray signal intensities (corre-
sponding to expression levels) in the control, testosterone,
and testosterone + MAA samples were 6,815, 3,303 and
7,092, respectively (Additional file 2, Table S2A). These
values indicate repression by testosterone and induction
by testosterone + MAA as compared to testosterone, but
not when compared to vehicle control. The net result,
however, is that MAA blocks the repressive action of tes-
tosterone. Patterns such as these, where testosterone or
MAA block or reverse the response to the other agent,
characterize the genes in class III.
Real time qPCR validation
To confirm the results of the microarrays, qPCR analysis
was carried out for 15 genes representing five different
TFS groups (Figure 4 and Additional file 5, Table S4).
Results were in close agreement, although in several
cases fold-change values determined by qPCR were
greater than those obtained by microarray (e.g., 38.6-
fold induction of Tulp2 by testosterone + MAA vs. tes-
tosterone alone by qPCR, vs. 7.6-fold induction by
microarray; Additional file 5, Table S4). This finding is
consistent with the compression of expression ratios
commonly seen using microarrays.
Functional impact of MAA on androgen responsive gene
expression
Gene Ontology (GO) term analysis was carried out to
identify the functional gene categories (i.e., the GO
terms) enriched in the sets of genes that comprised each
major TFS group. These analyses were useful for eluci-
dating the functional consequences of testosterone and
MAA treatment and their interactions. A summary of
the major results is presented in Figure 5, with full
details provided in Additional file 3, Table S3A. Among
the gene groups showing no interaction between MAA
and testosterone (class I genes), 964 genes responded to
testosterone but not to MAA. The 472 class I genes up
regulated by testosterone (TFS group 9.1001) were most
highly enriched in GO terms associated with negative
regulation of apoptosis, ion binding and lipid metabo-
lism (Figure 5). In contrast, the 492 class I genes down
regulated by testosterone (TFS 9.2002) were enriched
for immune response, cytokine activity, chemotaxis and
extracellular matrix and developmental processes (Figure
5). Class II genes, whose responses are enhanced by tes-
tosterone and/or MAA, were distributed into three sub-
classes (Table 1), based on whether MAA enhanced
responses to testosterone (class IIa, 819 genes), testos-
terone enhanced responses to MAA (class IIb, 619
genes), or the enhancement was mutual (class IIc, 734
genes). Class IIa genes showed the highest enrichment
for lipid biosynthesis (TFS 8.0001), apoptosis, cell differ-
entiation, and regulation of biological processes (TFS
8.0002). Class IIb genes showed highest enrichment for
extracellular matrix, cell adhesion and chemotaxis (TFS
13.022), while class IIc genes showed highest enrich-
ment for plasma membrane (TFS 12.0011) and for
extracellular matrix, cell adhesion, and organ develop-
ment (TFS 12.0022). Class III genes were distributed
into subclasses, based on whether MAA blocked the
response to testosterone (IIIa, IIIc) or testosterone
blocked the response to MAA (IIIb, IIId) and whether
testosterone and MAA are active alone (IIIa, IIIb), or
not (IIIc, IIId). The largest TFS group in class IIIa (TFS
1.1000; 329 genes) showed greatest enrichment for cel-
lular and biopolymer metabolic processes, nucleic acid
binding, kinase activity and metal ion binding, and
included 55 genes that encode nuclear factors, indicating
a wide range of impact of MAA on testosterone
responses. Finally, the genes in class IIId, TFS group
10.0102, whose induction by MAA was blocked by tes-
tosterone, and whose suppression by testosterone was
only manifested when MAA was present, showed great-
est enrichment for extracellular region and defense
response (Figure 5 and Additional file 3, Table S3A).
Motif enrichment analysis
Species-conserved transcription factor binding site
motifs and 3’-UTR miRNA binding sites enriched in the
genes belonging to each TFS group were identified by
GSEA [40], as described under Methods. A total of 64
motifs enriched in 13 TFS groups were identified after
filtering out motifs not showing enrichment at p < 0.001
and TFS groups with no enriched motifs at p < 0.001.
Table 2 summarizes the results, and the discovered
motifs and miRNA binding sites are clustered in Addi-
tional file 6, Figure S2. Detailed information for each
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scores, is provided in Additional file 3, Table S3B.
Motifs enriched in the promoters of class I genes in
TFS group 9.2002 including binding sites for FOXO and
other forkhead family transcription factors, with FOXO
motifs showing the most significant enrichment (p =3 . 2
E06). Six Hox genes that were repressed by testosterone
(TFS 9.2002) or whose repression was mutually
enhanced by MAA and testosterone (TFS 12.0022), i.e.,
Hoxb5, Hoxb9, Hoxc6, Hoxc8, Hoxd3 and Hoxd13,a r e
putative targets of FOXO (Additional file 2, Table S2D),
suggesting an important role for Fox and Hox genes in
t h em o d u l a t i o no fA Ra c t i v i t yb yM A A .M o t i f sf o r
MEF2A, TCF/LEF and STAT5 factors were also
enriched among the class I TFS groups, as were 3’-UTR
binding sites for several miRNAs. The enriched motifs
for class II genes, whose response to testosterone and
MAA showed mutual enhancement, include binding
Figure 4 qPCR validation of microarray results for genes representative of five TFS groups. TM3-AR cells were treated with vehicle
(DMSO, -), testosterone (T), MAA (M), or with T + MAA (T+M), as in Figure 1B. qPCR analysis was carried out for the five indicated genes; their
TFS group assignments (Additional file 2, Table S2) are shown in parentheses. Two pools of TM3-AR cell RNA, each comprised on RNA isolated
from 3 independent cell cultures, were assayed and are represented by the pair of bars in each treatment group. Data are mean ± SD values
based on n = 3 replicates, with the first vehicle control pooled sample set to 1.0. Significantly different from control at p < 0.05 (*) or at p < 0.01
(**); significantly different from T at p < 0.05 (#); and significantly different from MAA at p < 0.01 (++). qPCR primers used for this analysis are
shown in Additional file 1, Table S1.
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Page 8 of 14Figure 5 GO term enriched in TFS groups. Shown is a hierarchical clustering of GO terms that were significantly enriched (p < 0.0001, and
number of included genes >10) in at least one TFS group. GO terms are displayed at the right and TFS group numbers are shown across the
top. The color bar at the top left represents -log10 p-values, with higher numbers (darker colors) indicating more significant enrichment. A
complete list of enriched GO terms, p-values, enrichment scores and regulated genes in each GO term is provided in Additional file 2, Table S2A.
GO terms associated with apoptosis are in the boxed region at the top. TFS groups represent the following groups of genes 9.1001, genes
induced by testosterone, both without and with MAA present; 9.2002, genes suppressed by testosterone, both without and with MAA present;
8.0001, genes induced by testosterone, but only in the presence of MAA; 8.0002, genes suppressed by testosterone but only in the presence of
MAA; 12.0011, genes induced by testosterone + MAA, relative to testosterone alone and relative to MAA alone; 12.0022, genes suppressed by
testosterone + MAA, relative to testosterone and relative to MAA alone; 13.2022, genes suppressed by testosterone either alone or in
combination with MAA, and MAA enhances the suppression by testosterone; 1.1000, genes whose induction by testosterone is blocked by MAA;
and 10.0102, genes induced by MAA, but only in the absence of testosterone, and suppressed by testosterone, but only in the presence of MAA.
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distributed among several TFS groups (Table 2). Binding
sites for STAT5, TCF/LEF, FOXF2, PGR, MYCN and
several miRNAs were enriched in class III (TFS groups
1.1000, 2.0100 and 2.0200). These analyses also revealed
a large number of miRNA binding sites that are com-
mon to the 3’-UTR sequences of testosterone-regulated
genes.
Discussion
MAA, the active metabolite of the industrial chemical
ethylene glycol monomethyl ester, is an established testi-
cular toxicant. Earlier studies suggested that MAA could
potentiate AR transcriptional activity without signifi-
cantly altering the dose-response curve for androgen
activity, as determined in reporter gene studies [22].
Presently, the impact of MAA on expression of andro-
gen-regulated genes was characterized globally in a
mouse Leydig cell model. Mouse TM3 cells stably
expressing AR were treated with testosterone, MAA, or
with both chemicals in combination, and 5,532 genes
responding to one or more treatments were identified
and then classified, and sub-classified, based on their
patterns of response to each treatment. GO term and
motif enrichment analysis were carried out for genes in
each subgroup to help identify the biological functions
and pathways affected by MAA as it impacts cellular
responses to testosterone.
MAA has a wide range of impact on androgen responses
AR activated by testosterone can have direct effects on
target gene transcription [43], as well as indirect effects
mediated by intracellular signaling pathways. These
range from stimulation of protein kinases, to direct
modulation of voltage- and ligand-gated ion channels
and transporters [44], some of which may lead to
changes in gene expression [44]. Here, our microarray
analysis identified large numbers of genes that
responded to testosterone, a subset of whose responses
were modulated by MAA. These genes contribute to a
wide range of biological processes, including cell death,
development, ion binding, kinase activities and tran-
scription. These findings may help explain some of the
previous findings about the toxicities of MAA. For
example, MAA stimulates apoptosis of male germ cells
[19,23,45-48] by mechanisms proposed to involve var-
ious kinases and ion transporters [45,47]. Ion transport
is important for the maintenance of intracellular pH,
perturbation of which can affect germ cell fertility [49].
Proteins involved in transport comprise a large group of
MAA regulated genes, including genes whose expression
is affected by MAA alone, and genes that are additively
or synergistically regulated by MAA and testosterone.
For instance, GO term enrichment analysis identified 52
ion binding protein and 19 kinase genes that were sig-
nificantly enriched in the set of genes induced by testos-
terone whose induction is blocked by MAA (TFS group
1.1000). This same gene set showed enrichment for
genes that negatively regulate apoptosis. In contrast,
both positive and negative regulators of apoptosis were
enriched in the set of genes repressed by testosterone in
the presence of MAA (TFS group 8.0002). Further
investigation will be required to determine whether
these gene responses contribute to the testicular
Table 2 Transcription factors and miRNAs showing enrichment and potentially contributing to expression responses in
the indicated gene classes and TFS groups
Class TFS
group
Motif name miRNA name
I 9.1001 MEF2A -
9.2002 FOXO, LEF1, STAT5B, POU1F1, NFAT, TLX-2, GATA-1,





IIa 8.0002 E2F, TCF3, ETS-2, PAX4 -
IIb 4.0010 MEF2A -
4.0020 HOXA4, GCM1, RFX1, GATA3 MIR-24
13.2022 TAF -
IIc 12.0022 TCF8, FOXO, TAF MIR-524
IIIa 1.1000 STAT5B, STAT5A, PGR, LEF1, TCF3, FOXF2, E4F1 MIR-124A, MIR-17-5P, MIR-20A, MIR-106A, MIR-106B, MIR-20B, MIR-519D”,
MIR-182, MIR-200B, MIR-200C, MIR-429, MIR-202, MIR-199A, MIR-519E, MIR-9
IIIb 2.0100 MYCN, OLF1, MYOD1 -
2.0200 - MIR-493
- 11.1101 LEF1 -
Motifs and miRNAs within each TFS group are listed in order of decreasing enrichment p-value, based on data provided in Additional file 3, Table S3B.
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their relevance to humans exposed to MAA.
Transcription factors involved in MAA modulation of
testosterone response
TM3-AR cells showed complex patterns of response to
testosterone and MAA (Table 1), indicating that multi-
ple mechanisms likely contribute to MAA modulation
of responses to testosterone, and to testosterone modu-
lation of responses to MAA. One mechanisms could
involve effects of MAA on the expression of AR, whose
levels were increased ~2-fold by MAA, both in the
absence and in the presence of testosterone. While this
effect could conceivably contribute to the positive effects
of MAA on responses to testosterone (e.g., gene classes
IIa, IIc, and IIId; Table 1), it does not explain the inhibi-
tory effects of MAA on responses to testosterone seen
in gene classes IIIa and IIIc. Moreover, for many genes
in classes IIa, IIc and IIId, where MAA enhances
responses to testosterone, the magnitude of the effect of
MAA is greater than the observed ~2-fold increase in
AR expression. These findings suggest the involvement
of other transcription factors in the effects of MAA on
testosterone-responsive genes.
FOXO proteins can associate with AR and other
nuclear/steroid hormone receptors, leading to either
inhibition or enhancement of receptor transcriptional
activity [12]. These interactions have the potential to
impact the development of hormone-dependent cancers,
including prostate, breast and ovarian cancer [12]. Here,
we found that FOXO motifs were enriched in 53 genes
repressed by testosterone irrespective of whether MAA
was present (11% of the genes in TFS group 9.2002),
and in 12 genes down-regulated by testosterone, but
only when MAA was present, and vice versa (15% of
genes in TFS group 12.0022) (Additional file 2, Table
S2D). These findings suggest that FOXO factors plays
an important role in cellular responses to testosterone
and their modulation by MAA. 18 of the potential
FOXO targets are involved in transcription regulation,
including 6 Hox genes (Hoxb5, Hoxb9, Hoxc6, Hoxc8,
Hoxd3 and Hoxd13) (Additional file 2, Table S2D). Of
note, loss of Hoxc6 has been reported to induce apopto-
sis [50]. Moreover, 16 of the 65 FOXO target genes
down regulated by testosterone are associated with
developmental processes, as indicated by their GO
terms. Based on our microarray signal intensity data, at
least three FOXO genes are either highly expressed
(Foxo1) or moderately expressed in untreated TM3-AR
cells (Foxo6, Fox3a), suggesting these factors may med-
iate the effects on FOXO target genes. FOX family
genes are primarily regulated through the phosphoinosi-
tide-3-kinase (PI3k)-Akt pathway via phosphorylation
and nuclear exclusion [11], which is consistent with our
earlier finding that the PI3K/Akt pathway is required for
the effects of MAA on AR transcriptional activity [22].
Two other transcription factors that are expressed in
TM3-AR cells and may be involved in the interactions
between testosterone and MAA are LEF/TCF and
STAT5. Binding sites for LEF/TCF are significantly
enriched in several sets of genes that are regulated by
testosterone and MAA, while binding sites for STAT5
are enriched in genes repressed by testosterone (TFS
group 9.2002) and in genes whose induction by testos-
terone was blocked by MAA (TFS group 1.1000) (Table
2; Additional file 3, Table S3B). These findings are con-
sistent with reports that STAT5 and LEF/TCF can mod-
ulate AR-regulated gene responses, with STAT5
showing positive interactions with AR [8], and LEF/TCF
either repressing or enhancing AR activity [14]. Simi-
larly, our finding that binding sites for MEF2 are
enriched in TFS groups responsive to testosterone or
MAA (Table 2) is consistent with the finding that bind-
ing sequences for MEF2 family transcription factors are
commonly found near binding sites for AR, at least in
muscle cells [51].
Possible roles for miRNAs in MAA and testosterone
responses
miRNAs are short, ~22 nucleotides long RNAs that gen-
erally bind to 3’-UTR sequences of target mRNAs,
resulting in post-transcriptional mRNA down regulation
and translational repression [52]. Here, we identified
several miRNAs whose putative target sites are over-
represented in genes responsive to MAA or testoster-
one, suggesting a possible role for these miRNAs in
mediating responses to MAA and and testosterone.
Genes in TFS group 1.1000, whose induction by testos-
terone was blocked by MAA, were enriched in 3’-UTR
binding sites for the largest number of miRNAs (Table
2). These include mir-9 and miR-519e, which have been
reported to down regulate AR protein [53]. Conceivably,
MAA could induce these two miRNAs, which in turn,
would down regulate AR protein and functional activity.
Two other miRNAs whose binding sites were enriched
in the genes of TFS group 1.1000, namely mir-20A and
mir-202, are induced in testicular tubules following sup-
pression of FSH and androgen [54], which leads to a
block in spermiation. The enrichment of these miRNAs
in TFS 1.1000 genes suggests that testosterone may
down regulate these miRNAs, which would, in turn,
lead to the observed up regulation (de-repression) of the
TFS 1.1000 genes with mir-20A and mir-202 sites.
Moreover, the inhibition of this gene induction by MAA
suggests that MAA may block or perhaps reverse the
down regulation of these miRNAs by testosterone.
Further study is required to determine the effects of tes-
tosterone and MAA on these and other testis-expressed
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Page 11 of 14miRNAs, and their impact of spermatogenesis and the
toxicities associated with MAA exposure.
Impact of testosterone and MAA on expression of CYP
and GST genes
CYP (cytochrome P450) and GST (glutathione S-trans-
ferase) enzymes metabolize a broad range of endogen-
ous and exogenous compounds. Here, we found that the
expression of 20 CYP and 12 GST genes was affected by
either MAA or testosterone (Additional file 2, Table
S2E). Nine of these genes were induced by MAA alone
(Cyp2d22, Cyp26a1, Cyp26b1, Gstk1, Gstm6, Gstm7,
Gstt2, Mgst2 and Mgst3), while four genes were induced
by MAA but down regulated by testosterone (Cyp1a1,
Cyp2s1, Cyp2f2 and Mgst3). Three CYPs that show
female-predominant expression in mouse liver [55] were
further induced by testosterone in the presence of MAA
compared to testosterone treatment alone (Cyp2b9,
Cyp2b10 and Cyp2b13). Further studies are needed to
determine whether these enzymes play a metabolic role
in MAA modulation of testosterone signaling and/or the
detoxification of MAA.
Conclusions
This study investigated on a genome-wide basis the
impact of MAA on AR activity in a cultured Leydig cell
model. MAA displayed widespread effects on androgen-
responsive genes associated with diverse cellular pro-
cesses, including apoptosis, ion transport, cell adhesion,
phosphorylation and transcription. Binding sites for
FOXO, HOX, LEF/TCF, STAT5 and MEF2 family tran-
scription factors, as well as those of several miRNAs,
w e r ef o u n dt ob ee n r i c h e di nv a r i o u sg r o u p so fg e n e s
r e g u l a t e db yt e s t o s t e r o n ea n d / o rM A A .T h e s ef i n d i n g s
highlight the complex interactions, both positive and
negative, between androgen- and MAA-responsive
genes, and provide insight into molecular mechanisms
that may contribute to the toxicities associated with
exposure to MAA in testicular cells in vivo.
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analyzed by qPCR.
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summary of genes that respond to testosterone and/or MAA.
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motifs (B)
Additional file 4: Figure S1: Networks associated with genes
impacted by MAA, as identified by Ingenuity Pathway Analysis. (A)
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biochemistry and lipid metabolism; (B) Small molecule biochemistry, lipid
metabolism and drug metabolism. Dashed arrows indicate regulation of
gene expression, arrows with solid lines represent protein-DNA
interactions, and solid lines indicate protein-protein interactions. Lines in
blue identify processes and factors directly connected to testosterone.
Additional file 5: Table S4: Comparison of gene expression ratios
determined by qPCR and microarray analysis for 15 genes
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Additional file 6: Figure S2: Motifs enriched in different TFS groups.
Shown are motifs (A) and miRNAs (B) with enrichment p-value <
0.001 in at least one TFS group and TFS groups which have at least
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